Research Article
[Retracted] Diagnostic Value of IGFBP-2 in Predicting Preeclampsia before 20 Weeks of Pregnancy: A Prospective Nested Case-Control Study
Table 2
Analysis of high-risk factors and adverse outcomes between the NC group and PE groups.
| | PE () | NC () | OR (95% CI) | |
| | High-risk factors | | Anemia, (%) | 44 (36.07) | 14 (11.48) | 4.35 (2.20-8.45) | <0.01 | | History of diabetes | 0 (0) | 0 (0) | N | N | | History of hypertension | 1 (0.8) | 0 (0) | N | 0.99 | | , (%) | 39 (31.97) | 37 (30.33) | 1.08 (0.63-1.85) | 0.78 | | , (%) | 49 (40.16) | 39 (31.97) | 1.43 (0.84-2.38) | 0.18 | | History of preterm birth, (%) | 1 (0.8) | 1 (0.8) | N | N | | , (%) | 11 (9.02) | 7 (5.74) | 1.63 (0.61-4.19) | 0.33 | | Cesarean delivery, (%) | 21 (17.21) | 3 (2.46) | 8.25 (2.67-26.67) | <0.01 | | Stillbirths, (%) | 1 (0.8) | 0 (0) | N | 0.99 | | Adverse pregnancy and perinatal outcomes | | High risk of Down’s screening, (%) | 30 (24.60) | 15 (12.30) | 2.33 (1.18-26.67) | 0.01 | | Scar uterus, (%) | 24 (19.67) | 3 (2.46) | 9.71 (2.93-31.19) | <0.01 | | Oligohydramnios, (%) | 21 (17.21) | 1 (0.8) | 25.16 (4.41-263.70) | <0.01 | | Premature rupture of membranes, (%) | 25 (20.49) | 15 (12.30) | 1.84 (0.94-3.66) | 0.08 | | Placenta abnormality, (%) | 14 (11.48) | 4 (3.28) | 3.82 (1.28-10.89) | 0.03 | | Postpartum hemorrhage, (%) | 1 (0.8) | 4 (3.28) | 0.24 (0.02-1.51) | 0.37 | | Preterm birth, (%) | 3 (2.46) | 0 (0) | N | 0.25 | | Fetal weight (<2500 g) | 35 (28.69) | 1 (0.8) | 49.08 (8.21-505.90) | <0.01 |
|
|
N: defy calculation.
|
